Tower Research Capital LLC TRC Acquires 19,467 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Tower Research Capital LLC TRC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 104.3% in the 4th quarter, Holdings Channel.com reports. The fund owned 38,136 shares of the company’s stock after purchasing an additional 19,467 shares during the period. Tower Research Capital LLC TRC’s holdings in GE HealthCare Technologies were worth $2,981,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of GEHC. Morse Asset Management Inc acquired a new position in GE HealthCare Technologies during the 3rd quarter worth about $613,000. Diamant Asset Management Inc. lifted its stake in shares of GE HealthCare Technologies by 4.2% in the third quarter. Diamant Asset Management Inc. now owns 10,257 shares of the company’s stock worth $963,000 after acquiring an additional 410 shares during the period. World Investment Advisors LLC boosted its holdings in GE HealthCare Technologies by 44.5% in the third quarter. World Investment Advisors LLC now owns 4,716 shares of the company’s stock valued at $443,000 after acquiring an additional 1,453 shares during the last quarter. Wilmington Savings Fund Society FSB increased its position in GE HealthCare Technologies by 150.2% during the 3rd quarter. Wilmington Savings Fund Society FSB now owns 11,278 shares of the company’s stock valued at $1,058,000 after purchasing an additional 6,770 shares during the period. Finally, Tidal Investments LLC raised its holdings in GE HealthCare Technologies by 32.5% during the 3rd quarter. Tidal Investments LLC now owns 23,715 shares of the company’s stock worth $2,226,000 after purchasing an additional 5,819 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on GEHC shares. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and increased their price objective for the stock from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company lifted their price objective on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Citigroup upped their target price on GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a “neutral” rating to a “buy” rating and lifted their target price for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, BTIG Research set a $95.00 price target on GE HealthCare Technologies and gave the stock a “buy” rating in a report on Monday, April 14th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average target price of $97.27.

GE HealthCare Technologies Price Performance

Shares of NASDAQ GEHC opened at $60.48 on Tuesday. GE HealthCare Technologies Inc. has a fifty-two week low of $57.65 and a fifty-two week high of $94.80. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The firm’s 50-day simple moving average is $78.76 and its 200 day simple moving average is $82.77. The stock has a market cap of $27.69 billion, a price-to-earnings ratio of 13.97, a PEG ratio of 3.19 and a beta of 1.14.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.33 billion. As a group, research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, April 25th. This represents a $0.14 dividend on an annualized basis and a yield of 0.23%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 3.23%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.